Gene · 466
Papers2,331
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,331
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study. | Int J Mol Sci | 2022 | 36614077 | PubTator, text mining | PubMed |
| Genomic and Transcriptional Profiling of Chinese Melanoma Patients Enhanced Potentially Druggable Targets: A Multicenter Study. | Cancers (Basel) | 2022 | 36612279 | PubTator, text mining | PubMed |
| Primary pulmonary hyalinising clear cell carcinoma: Two cases and literature review. | Malays J Pathol | 2022 | 36591718 | PubTator, text mining | PubMed |
| Clear-Cell Sarcoma With an Unusual Presentation Mimicking Metastatic Melanoma. | Cureus | 2022 | 36589177 | PubTator, text mining | PubMed |
| Whole-genome characterization of myoepithelial carcinomas of the soft tissue. | Cold Spring Harb Mol Case Stud | 2022 | 36577525 | PubTator, text mining | PubMed |
| Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways. | Acta Pharm Sin B | 2022 | 36562002 | PubTator, text mining | PubMed |
| Prognostic Value of Serum Transferrin Analysis in Patients with Ovarian Cancer and Cancer-Related Functional Iron Deficiency: A Retrospective Case-Control Study. | J Clin Med | 2022 | 36555993 | PubTator, text mining | PubMed |
| The Similarities and Differences between the Effects of Testosterone and DHEA on the Innate and Adaptive Immune Response. | Biomolecules | 2022 | 36551196 | PubTator, text mining | PubMed |
| Expanding the spectrum of "mesenchymal" tumors of the central nervous system. | Pathologica | 2022 | 36534424 | PubTator, text mining | PubMed |
| cAMP-Dependent Signaling and Ovarian Cancer. | Cells | 2022 | 36497095 | PubTator, text mining | PubMed |
| Combination chemotherapy of doxorubicin and ifosfamide with proton beam therapy for myoepithelial carcinoma originating in the paraspinal region: A case report and literature review. | Mol Clin Oncol | 2022 | 36482942 | PubTator, text mining | PubMed |
| Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma. | iScience | 2022 | 36465101 | PubTator, text mining | PubMed |
| Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virus. | Sci Rep | 2022 | 36446841 | PubTator, text mining | PubMed |
| Genomic disparities between cancers in adolescent and young adults and in older adults. | Nat Commun | 2022 | 36433963 | PubTator, text mining | PubMed |
Heat Shock Transcription Factor 2 Is Significantly Involved in Neurodegenerative Diseases, Inflammatory Bowel Disease, Cancer, Male Infertility, and Fetal Alcohol Spectrum Disorder: The Novel Mechanisms of Several Severe Diseases. | Int J Mol Sci | 2022 | 36430241 | PubTator, text mining | PubMed |
| A Concise Review on Dysregulation of LINC00665 in Cancers. | Cells | 2022 | 36429005 | PubTator, text mining | PubMed |
| SNP-Target Genes Interaction Perturbing the Cancer Risk in the Post-GWAS. | Cancers (Basel) | 2022 | 36428729 | PubTator, text mining | PubMed |
| AAV process intensification by perfusion bioreaction and integrated clarification. | Front Bioeng Biotechnol | 2022 | 36420444 | PubTator, text mining | PubMed |
| A rare case of clear cell sarcoma of the foot with a cascade of pathological misdiagnosis-the importance of expert sarcoma pathology. | Ecancermedicalscience | 2022 | 36405939 | PubTator, text mining | PubMed |
| Accurate Identification of DNA Replication Origin by Fusing Epigenomics and Chromatin Interaction Information. | Research (Wash D C) | 2022 | 36405252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/466/papers?page=16